Beneficient earnings date
Want to see BENF full AI Analyst Report?
Beneficient (BENF) Q3 2026 Earnings Report
BENF Q3 2026 EPS Results
- Actual EPS
- $0.04
- Consensus EPS
- -$0.94
- Beat/Miss
- Beat by +$0.98
- One Year Ago EPS
- -$10.56
BENF Q3 2026 Revenue Results
- Actual Revenue
- $198.00K
- Expected Revenue
- $12.14M
- Beat/Miss
- Missed by -$11.94M
- YoY Revenue Growth
- -1.00%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 02/17/2026
- Time
- After Close
- Conference Call
- Tuesday, February 17, 2026
Beneficient's next earnings date is estimated for February 17, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call described several important stabilizing and corrective actions — regaining NASDAQ compliance, a GWG settlement within insurance limits, cost reductions (6.5% quarter, 18% YTD), $50M in proceeds and targeted debt paydowns — that position the company to rebuild momentum. However, these positives are counterbalanced by material operational and financial challenges: large quarterly and year-to-date operating losses, negative adjusted revenues, substantial declines in investments and NAV (roughly 29% and ~32%, respectively), reduced interest income (down ~25% YTD), low cash versus ~$100M of debt largely tied to former CEO-related entities, and ongoing legal uncertainty tied to the former CEO. Given the scale of the financial deterioration and lingering legal/balance-sheet risks relative to the accomplishments, the negatives outweigh the positives.
Management’s forward guidance emphasized stabilizing and re‑scaling the core liquidity and GP primary‑financing business while continuing expense and capital‑structure simplification: they plan further expense reductions after already cutting adjusted operating expenses 6.5% year‑over‑year and 18% year‑to‑date (ex. one‑time items), intend to close additional liquidity and GP primary financings (having closed a ~$3.0M NAV deal in December) and to act on a spring pipeline of opportunities, and will leverage a technology/AI‑enhanced platform to increase loan‑portfolio capacity (current net loan portfolio $188M, investments at fair value ~$206M). Management also reiterated balance‑sheet priorities — having generated about $50M gross proceeds from asset sales/redemptions (used in part to reduce debt, including ~$27.5M to a Texas State Bank), ending the quarter with $7.9M cash and $100.3M total debt (all but $3.7M tied to the former CEO’s entities) — and said it will consider litigation to challenge over $100M (≈$120M) of purported debt; they noted a $44.1M fair‑value increase in a derivative that settles in January 2028 and signaled plans to broaden channels (advisers, family offices, private banks) and demonstrate the business via a handful of transactions.
- Regained NASDAQ ComplianceBeneficient regained full compliance with NASDAQ continued listing requirements in January after completing an annual audit, filing multiple periods in a compressed timeframe, improving balance sheet equity and increasing stock price to meet the minimum listing threshold.
- Cost Reductions in Operating ExpensesAdjusted operating expenses declined 6.5% year-over-year for the quarter and 18% year-to-date (excluding one-time and nonrecurring items), reflecting management focus on expense discipline and platform efficiency.
- Capital Generation and Debt ReductionGenerated approximately $50 million in gross proceeds year-to-date through asset sales and equity redemptions; used proceeds to reduce payables and systemically reduce debt, including approximately $27.5 million paid to a Texas State Bank.
- Settlement and Legal MilestoneReached final court-approved settlement related to the GWG Holdings litigation within the limits of existing insurance policies, removing a material legal overhang tied to that matter.
- Return to Market ActivityClosed the first new GP primary commitment financing since June of last year in December, a transaction of approximately $3.0 million NAV, signaling renewed market interest in the company’s financing products.
- Diversified Collateral Supporting Loan PortfolioInvestments serving as collateral supported Ben Liquidity's loan portfolio with approximately 150 private market funds and ~430 underlying investments across asset classes, sectors and geographies (investments fair value $205.8M as of Dec 31, 2025).
- Focus on Business Simplification and AI-Enhanced PlatformManagement emphasized a strategy to build a more efficient technology and AI-enhanced services platform to improve operational efficiency, deliver profitable deal flow and broaden financing options going forward.
- Cash and Liquidity ActionsCompany ended the quarter with cash and cash equivalents of $7.9 million and has been actively pursuing additional simplification of capital structure and expense reduction to strengthen financial position.
BENF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 17, 2027 | 2027 (Q3) | 0.19- | 0.04 | ― | ― |
| Nov 16, 2026 | 2027 (Q2) | 0.15-1.49 | -2.96 | 49.66% (+1.47) | |
| Aug 14, 2026 | 2027 (Q1) | -2.06-0.47 | -57.52 | 99.18% (+57.05) | |
| Jun 29, 2026 | 2026 (Q4) | -0.96-12.00 | -13.08 | 8.26% (+1.08) | |
| Feb 17, 2026 | 2026 (Q3) | -0.940.04 | -10.56 | 100.38% (+10.60) | |
| Nov 14, 2025 | 2026 (Q2) | -0.20-0.37 | 0.24 | -254.17% (-0.61) | |
| Oct 21, 2025 | 2026 (Q1) | -2.16-2.96 | 0.24 | -1333.33% (-3.20) | |
| Sep 29, 2025 | 2025 (Q4) | ―-57.52 | -9.28 | -519.83% (-48.24) | |
| Feb 13, 2025 | 2025 (Q3) | -3.04-10.56 | -158.26 | 93.33% (+147.70) | |
| Nov 14, 2024 | 2025 (Q2) | -2.320.24 | -115.77 | 100.21% (+116.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

